电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

TWEAK Protein (AA 97-249)

TNFSF12 宿主: 人 宿主: 大肠杆菌(E. Coli) Recombinant > 98 % , as determined by Coomassie stained SDS-PAGE. BCA Active
产品编号 ABIN2666449
发货至: 中国
  • 抗原 See all TWEAK (TNFSF12) 蛋白
    TWEAK (TNFSF12) (Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12))
    蛋白类型
    Recombinant
    生物活性
    Active
    产品特性
    AA 97-249
    宿主
    • 15
    • 5
    • 2
    资源
    • 11
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    大肠杆菌(E. Coli)
    应用范围
    Biochemical Assay (BCA)
    纯度
    > 98 % , as determined by Coomassie stained SDS-PAGE.
    内毒素水平

    Less than 0.1 ng per μg of protein.

    Top Product
    Discover our top product TNFSF12 蛋白
  • 应用备注
    Optimal working dilution should be determined by the investigator.
    说明

    Biological activity: ED50 < 10 ng/ml, corresponding to a specific activity of > 1 x 107 units/mg, as determined by the dose dependent stimulation of production of IL-8 by human PBMC.

    限制
    仅限研究用
  • 状态
    Lyophilized
    溶解方式
    For maximum results, quick spin vial prior to opening. Reconstitute in 10 mM sodium phosphate, pH 7.5 to a concentration of 1.0 mg/mL. Do not vortex. It is recommended to further dilute in a buffer containing a carrier protein such as 0.1 % BSA and store working aliquots at -20 °C to -80 °C.
    缓冲液
    Lyophilized
    注意事项
    Avoid repeated freeze/thaw cycles.
    储存条件
    -20 °C
    储存方法
    Unopened vial can be stored at -20°C or -70°C.
  • 抗原
    TWEAK (TNFSF12) (Tumor Necrosis Factor (Ligand) Superfamily, Member 12 (TNFSF12))
    别名
    TWEAK (TNFSF12 产品)
    别名
    APO3L Protein, DR3LG Protein, TWEAK Protein, Apo3l Protein, Dr3l Protein, Dr3lg Protein, Tweak Protein, TNF superfamily member 12 Protein, tumor necrosis factor (ligand) superfamily, member 12 Protein, TNFSF12 Protein, Tnfsf12 Protein
    背景
    TWEAK (TNFSF12) is a "TNF-like weak inducer" of apoptosis through a non-death domain-dependent mechanism. TWEAK is a type II membrane protein which exhibits a single internal hydrophobic domain of 27 amino acids in the N-terminal region. TWEAK is proteolytically cleaved to produce a soluble cytokine that signals as a trimerized molecule. Fibroblast growth factor-inducible 14 (Fn14)/TWEAKR has been described as a receptor for TWEAK, and it is associated with proliferation of endothelial cells and angiogenesis. However, TWEAK mediates signal transduction and linear differentiation of monocyte/macrophage cells lacking Fn14/TWEAKR, suggesting that such cells contain an alternative TWEAK receptor. Elevated levels of TWEAK and/or Fn14 have been found to be associated with the pathogenesis of rheumatoid arthritis, skeletal muscle wasting, systemic lupus erythematosus, multiple sclerosis, stroke, neuroinflammation and neurodegeneration, and several types of cancer. The pathological functions of TWEAK are primarily attributed to its ability to induce the expression of several proinflammatory cytokines, chemokines, cell adhesion molecules, and matrix-degrading enzymes mainly through the activation of NF-κB, a major proinflammatory transcription factor. It has been described that CD163 (a scavenger receptor) might be acting as a receptor decoy for the ligand TWEAK.
    分子量
    The 154 amino acid N-terminal methionylated recombinant protein has a predicted molecular mass of 17 kDa.
    途径
    Apoptosis
You are here:
客服